about
Vaccines: the Fourth CenturyProspects and applications of nanobiotechnology: a medical perspectiveNasal vaccine innovation.Evaluation of mucoadhesive PLGA microparticles for nasal immunization.The performance of nanocarriers for transmucosal drug delivery.Use of degradable and nondegradable nanomaterials for controlled release.Nanoparticles as protein and gene carriers to mucosal surfaces.Non-invasive administration of biodegradable nano-carrier vaccines.Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.Bioadhesive delivery systems for mucosal vaccine delivery.Controlled release matrices and micro/nanoparticles of chitosan with antimicrobial potential: development of new strategies for microbial control in agriculture.Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine delivery.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Mucosal vaccine delivery: Current state and a pediatric perspectiveCurrent prospects and future challenges for nasal vaccine delivery.In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.Multifunctional nanoparticles for gene delivery and spinal cord injury.Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.A Potential Nanomedicine Consisting of Heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma
P2860
Q27490454-2C486DD1-85EA-447D-88F7-B1BD9448370EQ28387616-61BEFBB2-EE30-438A-AD4C-0DC02692D443Q30395810-FE75E6FA-7F5A-482E-B72D-20D7F055ED2BQ33749489-67D6F44F-62E8-4EB2-BBD2-B4F98CAB951CQ36527739-53D3A15B-0F2F-4F74-BBEF-8C2453693704Q36917951-EC389CDC-C707-4283-9BD2-4CB0E638DDABQ37331802-E7352EF3-C1D5-4378-A3B9-1E7CF7BF258BQ37596856-74227AAE-1E0C-4B6E-AB9D-EEBBC5A25767Q37671847-66164635-3C43-41C6-B81B-A369D6996088Q37805519-8577E5B1-158F-4AB5-8EAC-C3D65DBDE265Q38091370-849339C8-EC33-4F64-8668-4410470F9542Q38105259-A75DC3E4-96A7-4084-8F27-EC2DF7511479Q38461061-CBA29DC1-CE66-456A-AB06-524E558693A2Q38727453-4D109E24-32E5-485C-AB1F-66977ED840BAQ38784950-2DFE023C-8273-4995-8565-501B81F25960Q39574217-007BA8FB-B8AE-4C61-85A4-EE8687073619Q45875230-AC240C15-7C4A-4D90-84E2-B06AFC177888Q50908997-D8F7C662-11BE-45BF-8DD5-345E0D184CEBQ56992635-20DC7E7F-88C5-47F0-8BF3-BA8795AD2136
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nanoparticles as carriers for nasal vaccine delivery.
@ast
Nanoparticles as carriers for nasal vaccine delivery.
@en
type
label
Nanoparticles as carriers for nasal vaccine delivery.
@ast
Nanoparticles as carriers for nasal vaccine delivery.
@en
prefLabel
Nanoparticles as carriers for nasal vaccine delivery.
@ast
Nanoparticles as carriers for nasal vaccine delivery.
@en
P2860
P356
P1476
Nanoparticles as carriers for nasal vaccine delivery
@en
P2093
Alejandro Sánchez
Magnus Köping-Höggård
P2860
P304
P356
10.1586/14760584.4.2.185
P577
2005-04-01T00:00:00Z